Quarter in review – JIA
Dhrubajyoti Sharma, DM (Pediatric Clinical Immunology and Rheumatology)Associate Professor, Department of Pediatrics, Jorhat Medical College, Jorhat, Assam Juvenile Idiopathic Arthritis (JIA) and Kawasaki disease (KD) are two distinct diseases. However, they share many clinical features and biological markers such as IL-1β and IL-6. Arthritis can develop in approximately 7.5% patients with KD. Coronary artery abnormality […]
Quarter in review – Basic science
Sakir Ahmed MD DM, MNAMSAssociate Prof, Clinical Immunology and Rheumatology, Kalinga Institute of Medical SciencesConsultant Rheumatologist, KIMS Super Specialty Hospital, Bhubaneshwar, India Prakashini MV MDKalinga Institute of Medical Sciences, KIIT University, Bhubaneswar, India Study in focus 1: Combination of Two Monoclonal Anti–Citrullinated Protein Antibodies Induced Tenosynovitis, Pain, and Bone Loss in Mice in a Peptidyl […]
Quarter in review – Clinical Science
Arghya Chattopadhyay MD, DM Assistant Professor, Department of Rheumatology, North-Bengal Medical College & Hospital, Darjeeling. Study in focus 1: Baricitinib for systemic lupus erythematosus: a double-blind, randomised, placebo-controlled, phase 3 trial (SLE-BRAVE-I). JAK inhibitors have shown promising results in various arthritic conditions like rheumatoid arthritis (RA), psoriatic arthritis, ankylosing spondylitis etc. Baricitinib, a selective Janus […]
